Moderna: Tricky Road Ahead for mRNA-1273, Says 5-Star Analyst
Gilead Pours $300M Into Tizona’s Cancer Immunotherapy Pipeline
Coronavirus pharma news roundup – 17/07/20
Ending the pandemic will take global access to COVID-19 treatment and vaccines – which means putting ethics before profits
ICMRA seeks international alignment on COVID-19 product assessment
Aldeyra Spikes 10% In Pre-Market On New Perceptive Stake
Abbott Labs, Edwards Lifesciences Settle Heart Device Patent Disputes
Pfizer, BioNTech Score Fast Track Status For Covid-19 Vaccine Candidates
South Korea: 1 in 3 Covid-19 Patients Improved With Gilead’s Remdesivir
Futures Jump Above 3,200 On Vaccine Optimism, Merger Monday
Asian equities start week higher
Amgen Pours A Further $421M Into China’s BeiGene
BeiGene Plans $2B Direct Offering; Analyst Sees Further Upside Ahead
ElectroCore Pops 160% On FDA Nod For Covid-19 Asthma Device
Australia Provisionally Approves Gilead’s Covid-19 Treatment
Xeris Pharma Spikes 12% After-Hours On Soros Stake; Analyst Says Buy
Gilead Reveals Additional Data On Covid-19 Treatment Remdesivir
HHS allocates Gilead’s Covid-19 drug remdesivir to four hardest hit states
Remdesivir Shows Broader Effectiveness Against Covid-19
EU Close: Modest de-risking ahead of Earnings Season and on US virus concerns, Oil rises, Gold holds $1800 level
Coronavirus pharma news roundup – 10/07/20
Moderna Inks Deal With Rovi To Supply Potential Covid-19 Vaccine Outside U.S.
What explains the decline in COVID deaths despite the rising number of cases?
New study supports remdesivir as COVID-19 treatment
Gilead starts trials of inhaled remdesivir for earlier-stage COVID-19
A new study points to $6.5B in public support building the scientific foundation of Gilead's remdesivir. Should that be reflected in the price?
US snaps up first supplies of Regeneron’s COVID-19 antibody
UK trial begins testing second-wave COVID-19 drug from US biotech Ridgeback
Chembio Gains 12% After-Hours On New Covid-19 BARDA Contract
Regeneron Up 5% In Pre-Market On Start Of Late-Stage Covid-19 Antibody Trial